Bolt Navigation: Series B Funding Round Closed

By Dan Anderson ● Jan 22, 2024

Bolt Navigation – a privately held leading developer of Handheld Surgical Navigation systems – recently announced that it has closed its Series B financing. The funding round was once again led by Grand Oaks Capital, the investment group for the family office of Paychex founder Tom Golisano, with participation from Impact Capital of New York. And Tom Bonadio, Impact Capital’s General Partner and Chairman of Board of Directors at The Bonadio Group, will join the company’s board.

The funding will be used to support commercialization of the Bolt Navigation System in the U.S., EU and other markets, ongoing and new clinical studies, and expansion of the Bolt technology platform into additional indications.

The company’s handheld products empower and enhance a surgeon’s capabilities with cutting-edge technology that meaningfully reduces radiation exposure, fits seamlessly into the surgical workflow, is cost-effective, and is implant-agnostic. The mission is to benefit patients worldwide by making cutting-edge navigation available to skilled surgeons in any setting, anyplace in the world. Smaller, Safer, Faster, Better.

KEY QUOTES:

“We are delighted to have the continued support of Grand Oaks Capital and new investors seasoned in guiding commercial stage companies. We are in a position to execute on our goals of commercializing the Bolt Navigation System, a cutting-edge handheld spine navigation solution. The iOS-based system combines exceptional accuracy, cost-effectiveness, reduced radiation exposure, and seamless integration with existing surgical workflows, setting a new standard in the field.”

  • Patrick West, Chief Executive Officer of Bolt

“We are pleased to support the continued financing of, and have confidence in, the Company’s technology and business strategy. We look forward to the company reaching its critical milestones for its novel navigation technology that enables greater access to a technology that benefits patients, surgeons, and surgical staff.”

  • David Bovenzi, Grand Oaks Capital’s Chief Investment Officer